The role of vehicle metamorphosis on Triamcinolone (cas 124-94-7) acetonide delivery to the skin from microemulsions
-
Add time:09/26/2019 Source:sciencedirect.com
After application to the skin surface, a topical formulation is submitted to changes in composition produced by evaporation of volatile components, penetration of components into the skin and extraction of skin components (“vehicle metamorphosis”). The aim of this work was to study the effect of vehicle metamorphosis on skin delivery from microemulsions containing Triamcinolone (cas 124-94-7) acetonide. The microemulsions were prepared and characterized for water evaporation kinetics, in vitro release and skin permeation and retention. Skin retention experiments were performed on full thickness pig ear skin, in both occluded infinite and un-occluded finite dose conditions. For comparison purposes, two creams, the commercial Ledercort® and a vanishing cream, were tested. With triamcinolone acetonide water evaporation does not modify skin retention, probably for the lipophilic nature of the drug. However, if water is eliminated from the microemulsions, the performance is reduced, probably because drug partitioning from vehicle to stratum corneum is disfavored. If a water-soluble drug (methyl prednisolone sodium succinate) is used, infinite dose application in occlusive conditions increases in a significant way the amount of drug retained in the skin. The involved mechanisms are probably stratum corneum swelling and increase of stratum corneum/viable epidermis partitioning.
We also recommend Trading Suppliers and Manufacturers of Triamcinolone (cas 124-94-7). Pls Click Website Link as below: cas 124-94-7 suppliers
Prev:Case reportMiliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of Triamcinolone (cas 124-94-7) acetonide
Next:From Lab to ClinicUrine Gene Expression Profiles in Bladder Pain Syndrome Patients Treated with Triamcinolone (cas 124-94-7)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Simultaneous determination of Triamcinolone (cas 124-94-7) hexacetonide and Triamcinolone (cas 124-94-7) acetonide in rabbit plasma using a highly sensitive and selective UPLC–MS/MS method10/01/2019
- From Lab to ClinicUrine Gene Expression Profiles in Bladder Pain Syndrome Patients Treated with Triamcinolone (cas 124-94-7)09/27/2019
- Case reportMiliary microemboli of the retinal arterioles and choriocapillaris after subcutaneous injection of Triamcinolone (cas 124-94-7) acetonide09/25/2019
- Clinical PaperClinical PathologyRole of intralesional bleomycin and intralesional Triamcinolone (cas 124-94-7) therapy in residual haemangioma following propranolol09/24/2019
- Randomized open-label trial comparing topical prescription Triamcinolone (cas 124-94-7) to over-the-counter hydrocortisone for the treatment of phimosis09/10/2019
- Microfibrillar polymeric ocular inserts for Triamcinolone (cas 124-94-7) acetonide delivery09/09/2019
- Comparison between the efficacy of intralesional rituximab versus intralesional Triamcinolone (cas 124-94-7) in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial09/08/2019
-
Health and Chemical more >